ARTICLE | Clinical News
THC:CBD: Phase I started
November 9, 2015 8:00 AM UTC
MMJ PhytoTech Ltd. (ASX:MMJ), Nedlands, Australia Product: THC:CBD Business: Autoimmune Molecular target: Cannabinoid receptors Description: Oral pro-nanolipospheres containing tetrahydrocannabinol (...